Eli Lilly’s Foundayo And Novo Nordisk’s Wegovy – A Look At Some Key Highlights
Lilly just announced positive results from its Phase 3 ACHIEVE-4 trial, boosting confidence in its experimental diabetes pill,…
FDA Approves Foundayo, a New Oral Weight-Loss Drug Like Ozempic
The U.S. Food and Drug Administration (FDA). Credit: Felton Davis / CC BY 2.0 The U.S. Food and…
Novo Nordisk Responds to Rival Launch with Clinical Data and Subscription Model
Novo Nordisk releases head-to-head data favoring oral Wegovy over Foundayo and launches a direct-to-consumer subscription plan to retain…
Eli Lilly Gets Speedy FDA Nod for Oral GLP-1 Drug, a Competitor to New Novo Nordisk Pill
Eli Lilly now has FDA approval for its GLP-1 obesity pill, introducing a convenient dosing alternative to injections…